POINT-HD has begun dosing its first participants with the drug RG6496, marking an early but important step for a new selective huntingtin-lowering approach.
CAG repeats can get longer over time as the HD gene is used, like the growing potholes and cracks in an old road. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback